CALGARY, Oct. 27, 2017 /CNW/ - Imperial Oil Limited today declared a quarterly dividend of 16cents per share on the outstanding common shares of the company, payable on January 1, 2018, to shareholders of record at the close of business on December 1, 2017.
This fourth quarter 2017 dividend compares with the third quarter 2017 dividend of 16 cents per share.
Imperial has a long and successful history of growth and financial stability in Canada as a leading member of the petroleum industry. The company has paid dividends every year for over a century and has increased its annual dividend payment for 23 consecutive years.
After more than a century, Imperial continues to be an industry leader in applying technology and innovation to responsibly develop Canada's energy resources. As Canada's largest petroleum refiner, a major producer of crude oil and natural gas, a key petrochemical producer and a leading fuels marketer from coast to coast, our company remains committed to high standards across all areas of our business.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...
TSX VENTURE COMPANIES
BULLETIN V2024-1211
ALPHAMIN RESOURCES CORP. ("AFM")BULLETIN TYPE: Declaration of DividendBULLETIN DATE: April 26, 2024TSX Venture Tier 2 Company
The Issuer has declared the following dividend:
Dividend Amount per Common...
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year ended January 31, 2024. The Company recorded net earnings and comprehensive income attributable to shareholders of the...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
